Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Hot Products

InnoCare Announces First Subject Dosed in Clinical Trial of BCL2 Inhibitor ICP-248 in China

PharmaSourcesMarch 10, 2023

Tag: ALL , inhibitor , Tumor

PharmaSources Customer Service